Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Lukas J A, Stalpers"'
Autor:
Ester P. Olthof, Brenda J. Bergink-Voorthuis, Hans H. B. Wenzel, Jordy Mongula, Jacobus van der Velden, Anje M. Spijkerboer, Judit A. Adam, Ruud L. M. Bekkers, Jogchum J. Beltman, Brigitte F. M. Slangen, Hans W. Nijman, Ramon G. V. Smolders, Nienke E. van Trommel, Petra L. M. Zusterzeel, Ronald P. Zweemer, Lukas J. A. Stalpers, Constantijne H. Mom, Maaike A. van der Aa
Publikováno v:
Insights into Imaging, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Objectives Imaging is increasingly used to assess lymph node involvement in clinically early-stage cervical cancer. This retrospective study aimed to evaluate the diagnostic accuracy of MRI, CT, and [18F]FDG-PET-CT. Methods Women with Intern
Externí odkaz:
https://doaj.org/article/d0fa9ae14884488382643f5adb6cfe0e
Autor:
Judit A. Adam, Edwin Poel, Berthe L. F. van Eck-Smit, Constantijne H. Mom, Lukas J. A. Stalpers, Jaap Stoker, Shandra Bipat
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Background Lymph node metastasis is an important prognostic factor in locally advanced cervical cancer (LACC). No imaging method can successfully detect all (micro)metastases. This may result in (lymph node) recurrence after chemoradiation.
Externí odkaz:
https://doaj.org/article/ce45affa04824d41be49e86e632031ca
Autor:
Janna J. Laan, Luc R. C. W. van Lonkhuijzen, Jaap A. Stokking, Danique L. J. Barten, Karel A. Hinnen, Bradley R. Pieters, Lukas J. A. Stalpers, Henrike Westerveld
Publikováno v:
Current Oncology, Vol 30, Iss 4, Pp 4275-4288 (2023)
(1) Background: Over the past two decades use of new imaging modalities and the adaptation of applicators have allowed for advances in volumetric (3D) imaging-based brachytherapy practices for patients with locally advanced cervical cancer. The aim o
Externí odkaz:
https://doaj.org/article/fcd74b32e9544e78a9242f366b13deac
Autor:
Akke Bakker, Remko Zweije, H. Petra Kok, Lukas J. A. Stalpers, G. Henrike Westerveld, Karel A. Hinnen, Geertjan van Tienhoven, M. Willemijn Kolff, Hans Crezee
Publikováno v:
International Journal of Hyperthermia, Vol 39, Iss 1, Pp 1408-1414 (2022)
Objective The in-house developed 70 MHz AMC-4 locoregional hyperthermia system has been in clinical use since 1984. This device was recently commercialized as the Alba 4D (Medlogix®, Rome, Italy), with a similar geometrical 4-waveguide design. At th
Externí odkaz:
https://doaj.org/article/73ea93929dad46a2a642a3e68544d0bd
Autor:
Soraya Gavazzi, Astrid L. H. M. W. van Lier, Cornel Zachiu, Eric Jansen, Jan J. W Lagendijk, Lukas J. A Stalpers, Hans Crezee, H. Petra Kok
Publikováno v:
International Journal of Hyperthermia, Vol 37, Iss 1, Pp 992-1007 (2020)
Hyperthermia treatment planning (HTP) is valuable to optimize tumor heating during thermal therapy delivery. Yet, clinical hyperthermia treatment plans lack quantitative accuracy due to uncertainties in tissue properties and modeling, and report tumo
Externí odkaz:
https://doaj.org/article/27fad9a0dc95494baa892fddfaf27b1d
Autor:
Arlene L. Oei, Preethi Korangath, Kathleen Mulka, Mikko Helenius, Jonathan B. Coulter, Jacqueline Stewart, Esteban Velarde, Johannes Crezee, Brian Simons, Lukas J. A. Stalpers, H. Petra Kok, Kathleen Gabrielson, Nicolaas A. P. Franken, Robert Ivkov
Publikováno v:
International Journal of Hyperthermia, Vol 36, Iss 0, Pp 47-63 (2019)
Purpose: Enhancing immune responses in triple negative breast cancers (TNBCs) remains a challenge. Our study aimed to determine whether magnetic iron oxide nanoparticle (MION) hyperthermia (HT) can enhance abscopal effects with radiotherapy (RT) and
Externí odkaz:
https://doaj.org/article/373ac4be0e8649e7bbb04b8ecf130b94
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Externí odkaz:
https://doaj.org/article/8472785c798b43afa08e9af57e40b205
Autor:
Caspar M. van Leeuwen, Arlene L. Oei, Kenneth W. T. K. Chin, Johannes Crezee, Arjan Bel, Anneke M. Westermann, Marrije R. Buist, Nicolaas A. P. Franken, Lukas J. A. Stalpers, H. Petra Kok
Publikováno v:
Radiation Oncology, Vol 12, Iss 1, Pp 1-8 (2017)
Abstract Background Combined radiotherapy and hyperthermia is a well-established alternative to chemoradiotherapy for advanced stage cervical cancer patients with a contraindication for chemotherapy. Pre-clinical evidence suggests that the radiosensi
Externí odkaz:
https://doaj.org/article/2bc8fa3a6c164e52a1053fc6770d7edc
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Externí odkaz:
https://doaj.org/article/64139ac0c09c4bd2ad52ba8917e4aef5
Publikováno v:
International Journal of Gynecologic Cancer. 32:288-296
Radiotherapy with cisplatin (chemoradiation) is the standard treatment for women with locally advanced cervical cancer. Radiotherapy with deep hyperthermia (thermoradiation) is a well established alternative, but is rarely offered as an alternative t